1. Volume 148, Issue 7, Pages 1353-1361.e3 (June 2015)
Population-Representative Incidence of Drug-Induced Acute Liver Failure Based on an Analysis of an Integrated Health Care System 
David S. Goldberg, Kimberly A. Forde, Dena M. Carbonari, James D. Lewis, Kimberly B.F. Leidl, K. Rajender Reddy, Kevin Haynes, Jason Roy, Daohang Sha, Amy R. Marks, Jennifer L. Schneider, Brian L. Strom, Douglas A. Corley, Vincent Lo Re 
Gastroenterology 
Volume 148, Issue 7, Pages e3 (June 2015)
DOI: /j.gastro
Copyright © 2015 AGA Institute Terms and Conditions

2. Figure 1
Flow diagram of study patients. *ICD-9 codes or †ICD-9 codes 570, 572.2, 572.4, 572.8, or V42.7. ‡Index date defined as the admission date of the hospitalization associated with the drug-induced hepatitis or ALF diagnosis code. §Patients may have had more than one exclusionary diagnosis recorded. anti-HBc, antibody to hepatitis B core antigen; HBeAg, hepatitis B e antigen; HBsAg, hepatitis B surface antigen; HBV, hepatitis B virus; HCV, hepatitis C virus; HDV, hepatitis delta virus.
Gastroenterology  , e3DOI: ( /j.gastro )
Copyright © 2015 AGA Institute Terms and Conditions